Skip to main content

Year in review · from our August 2026 register copy

NAFDAC registrations in 2021

By the approval dates our August 2026 copy of the Greenbook records, 2,496 products were approved onto the register in 2021 — 2,288 of them in Drugs. 44% of the class of 2021 is still active in our copy today.

By category

Month by month

Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.

Jan
127
Feb
168
Mar
295
Apr
1
May
390
Jun
187
Jul
5
Aug
450
Sep
242
Oct
270
Nov
27
Dec
334

Who registered the most

  1. 1.Onifam Laboratories50 approvals
  2. 2.Novartis Nigeria49 approvals
  3. 3.Afrab-Chem48 approvals
  4. 4.Phillips Pharmaceuticals (Nigeria)46 approvals
  5. 5.Drugfield Pharmaceuticals42 approvals
  6. 6.Fidson Healthcare42 approvals
  7. 7.SKG - Pharma42 approvals
  8. 8.Sanofi41 approvals
  9. 9.Me Cure Industries38 approvals
  10. 10.Micro Nova Pharmaceuticals Ind38 approvals

Where the year's medicines were made

Factory countries recorded on 2,178 of the year's 2,288 drug approvals.

Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.

Other years

Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.